Investigation of Protein Biomarkers of Prostate Cancer

This study has been completed.
Sponsor:
Information provided by:
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00323180
First received: May 5, 2006
Last updated: January 6, 2010
Last verified: November 2009
  Purpose

This study is looking at biomarkers in prostate cancer.


Condition
Prostate Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Investigation of Protein Biomarkers of Prostate Cancer

Resource links provided by NLM:


Further study details as provided by University of New Mexico:

Study Start Date: August 2005
Study Completion Date: February 2009
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Detailed Description:
  1. To establish primary culture of epithelial cells isolated from prostatectomy samples
  2. To study biomarkers in prostate cancer
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with prostate cancer

Criteria

Inclusion Criteria:

  • Patients with prostate cancer.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00323180

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Marco Bisoffi University of New Mexico
  More Information

No publications provided

Responsible Party: Marco Bisoffi; Principal Investigator, Universtiy of New Mexico
ClinicalTrials.gov Identifier: NCT00323180     History of Changes
Other Study ID Numbers: HRRC 03-376
Study First Received: May 5, 2006
Last Updated: January 6, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on April 17, 2014